Ekkio acquires French spa chain Calicéo

By Hannah Langworth

23rd July 2018

Ekkio Capital has acquired French spa chain Calicéo.

The investment is the third from Ekkio’s fourth fund, which closed in May 2018 at €161m.

Founded in 1996 as a family business, Calicéo operates six sites in Toulouse, Perpignan, Nantes, Pau, Lyon and Bordeaux which together have around 1 million visitors every year. The business has around €17m of annual revenues.

Ekkio was advised by Roland Berger, Aigis, Squire Patton Boggs, Archimède, Alcaix & Associés, Kéo and Oderis; and the sellers by Adviso Partners, Fidal and KPMG.

Senior debt to support the transaction was provided by LCL and mezzanine debt by Indigo. LCL was advised by HSF and Indigo by De Pardieu Brocas Maffei.

read the article on realdeals.eu.com

Laboratory Gravier revisits its shareholding with Ekkio Capital

 

If popularity for the bio is not to be anymore demonstrated in the food-processing industry, the phenomenon does not escape either the cosmetic. Since 2010, this market shows an annual growth of 6 % in France, for the biggest happiness of some actors who preside, following the example of Melvita, Weleda and Léa Nature, either still of Laboratory Gravel there. The latter moreover took advantage of these favorable winds to see again in depth his shareholding. Naxicap Partners, member of a minority party since 2010, records his exit for the benefit of Ekkio Capital, within the framework of a buy-out resting on a debt senior between 5 and 6 M€.

 

 

read the article on capitalfinance.lesechos.fr

BUILD UPSterience

Sterience pickaxe at German Vanguard for his first  add-on

By WS ¦ 28/09/2017 ¦ 10:38

A little more than two years after having “spinned-off” Sterience of the perimeter of Dalkia, Ekkio Capital accompanies this leader of outsourced sterilization of medical equipment in his first one build-up. The acquisition concerns an expert of the complex medical devices, Vanguard Medical Services France, the subsidiary of the german Vanguard. He appears …

read the full article on capitalfinance.lesechos.fr (french version only)

 

Pharmacie : Amatsigroup passes to form a part of Eurofins Scientific

Laurent Marcaillou, Les Echos

The Toulousian group of preparation of medicine for clinical trials is sold by the fund Ekkio Capital.

It joins one of the world leaders of biological analyses.

Read the article (french only) on LesEchos.fr

Novescia, THE CREATION OF EKKIO

Ekkio Capital had identified medicial analysis laboratories as fertile ground for investment, but could not find the right company to invest in. No problem, the team managed to build it.

 click for more .pdf